bpc-157 clinical trials registered trial and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, BPC-157 - 5 MG

By enhancing levels of dopamine, norepinephrine, and serotonin, tesofensine appears to suppress appetite and elevate mood, which may help mitigate some of the underlying drivers of stimulant misuse

No persistent GI symptoms above mild

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design

But theres no data showing how well it works in humans, and the long-term safety of this peptide in humans is simply unknown

Reconstitution of a copper-containing blend A blend that contains GHK-Cu is not a standard peptide reconstitution

Type 2 diabetes and glycemic control: Research explores its effects on fasting glucose, HbA1c, and postprandial glycemia via slowed gastric emptying, reduced food intake, and possible direct pancreatic/islet effects